Your browser doesn't support javascript.
loading
Anti-PD-1 Efficacy in Patients with Metastatic Urothelial Cancer Associates with Intratumoral Juxtaposition of T Helper-Type 1 and CD8+ T cells.
Rijnders, Maud; Balcioglu, Hayri E; Robbrecht, Debbie G J; Oostvogels, Astrid A M; Wijers, Rebecca; Aarts, Maureen J B; Hamberg, Paul; van Leenders, Geert J L H; Nakauma-González, J Alberto; Voortman, Jens; Westgeest, Hans M; Boormans, Joost L; de Wit, Ronald; Lolkema, Martijn P; van der Veldt, Astrid A M; Debets, Reno.
Afiliação
  • Rijnders M; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands.
  • Balcioglu HE; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands.
  • Robbrecht DGJ; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands.
  • Oostvogels AAM; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands.
  • Wijers R; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands.
  • Aarts MJB; Department of Medical Oncology, Maastricht University Medical Center+, Maastricht, the Netherlands.
  • Hamberg P; Department of Medical Oncology, Franciscus Gasthuis & Vlietland Hospital, Rotterdam, the Netherlands.
  • van Leenders GJLH; Department of Pathology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands.
  • Nakauma-González JA; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands.
  • Voortman J; Department of Urology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands.
  • Westgeest HM; Cancer Computational Biology Center, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands.
  • Boormans JL; Department of Medical Oncology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, the Netherlands.
  • de Wit R; Department of Medical Oncology, Amphia Hospital Breda, Breda, the Netherlands.
  • Lolkema MP; Department of Urology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands.
  • van der Veldt AAM; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands.
  • Debets R; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands.
Clin Cancer Res ; 28(1): 215-226, 2022 01 01.
Article em En | MEDLINE | ID: mdl-34615720
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T CD8-Positivos / Neoplasias Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T CD8-Positivos / Neoplasias Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda